期刊文献+

人甲状旁腺素(1-34)对新生Wistar大鼠成骨细胞增殖作用的影响 被引量:5

Effect of Parathyroid Hormone on Proliferation of Osteoblast in Neonatal Wistar Rat
下载PDF
导出
摘要 目的:研究外源性人甲状旁腺素(134)(hPTH(134))对原代培养Wistar新生鼠成骨细胞增殖作用的影响及蛋白激酶A(PKA)、蛋白激酶C(PKC)在此过程中作用。方法:Wistar大鼠成骨细胞原代培养,3HTdR掺入法测细胞增殖。结果:108mol/LhPTH(134)在以24h为一循环的前12h给药循环3次时3HTdR掺入较对照组增加32%,而107mol/LhPTH(134)对3HTdR掺入无影响。hPTH(134)72h持续作用组3HTdR掺入与对照组相比无明显差异。加入PKA抑制剂后阻断hPTH(134)引起3HTdR掺入增加,加入PKC抑制剂后部分阻断108mol/LhPTH(134)引起3HTdR掺入增加。hPTH(134)在1011~108mol/L范围内刺激细胞增殖与浓度成正相关。结论:PTH刺激成骨细胞增殖与给药方式及药物浓度有关,低浓度间歇性给与PTH能刺激成骨细胞增殖。 To investigate the effect of Parathyroid hormone (PTH) on proliferation of osteoblasts and the effect of protein kinase A (PKA) and protein kinase C (PKC) in this process, we isolate the osteoblasts from newborn Wistar rat and count 3H thymidine incorporation radioactivity. The result indicated that 10 9 、10 8 mol/L hPTH(1 34) significantly increase the 3H thymidine incorporation for the first 12h of each 24h incubation cycle for 3 cycles (P<0.01). 10 7 mol/L hPTH (1 34) treated the cells by this manner had no effect compared with the control (P>0.05). While given the osteoblasts with 10 8 mol/L hPTH (1 34) for 72h continuously, the 3H thymidine incorporation had no discrepancy compared with the control. PKA inhibitor blocked the effect of PTH on osteoblasts, while PCK inhibitor partially block this process. From 10 11 to 10 8 mol/L, the effect of PTH on osteoblast′s proliferation is positively relative to its concentration. So we could say, PTH has diverse effect on osteoblasts proliferation depending on the exposure time and its concentration in vitro, and PKA signal transduction systems had the major effect in this process.
出处 《基础医学与临床》 CSCD 1998年第6期33-37,共5页 Basic and Clinical Medicine
基金 国家自然科学基金
关键词 甲状旁腺素 成骨细胞 增殖 骨质疏松 治疗 human Parathyroid Hormone Osteoblasts proliferation
  • 相关文献

同被引文献29

  • 1郭世绂.骨质疏松症的药物治疗及其理论基础[J].中华骨科杂志,2004,24(11):691-695. 被引量:53
  • 2韩志岩,程锦轩,刘景生.人甲状旁腺素(1-34)对新生鼠成骨细胞钙含量及钙化结节形成的影响[J].中国骨质疏松杂志,1999,5(2):5-8. 被引量:2
  • 3王洪复,金慰芳,高建军.骨质疏松症防治药物的体外细胞药效评价[J].中国骨质疏松杂志,1999,5(2):58-62. 被引量:41
  • 4Keutmann HT,Sauer MM,Hendy GN etal.Complete amino acid sequence of human parathyroid hormone[J].Biochemistry,1978,17:5723.
  • 5Monier,Faugere MC,Geng Z,Mawad H.Improved assessment of bone turnover by the PTH(1-84)/large C-PTH fragments ratio in ESRD patients[J].Kidney Int,2001,60:1460-1468.
  • 6Dunlay B and Hruska K.PTH receptor coupling to phospholipase C is An alternate pathway of signal transduction in bone and kidney[J].Am J Physiol,1990,258:F223.
  • 7Julie MR,Amareshwar TK,Paula HS.Role of protein kinase A,phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase Ca and interleukin-6 in UMR-106 osteoblastic cells.Cellular Signalling,2004,16:105-114.
  • 8Neugebauer W,Gagnon L,Whitfield J etal.Structure and proteinkinase C stimulating activities of Lactam analogues of human parathyroid hormone fragment[J].Int J Peptide Protein Res,1994,43:555.
  • 9Harvey AK,Yu XP,Frolik CA.Parathyroid hormone(1-34) enhances aggrecan synthesis via an insulin-like growth factor-1 pathway.J Biol Chem,1999,13:274.
  • 10Kikkawa U,Matsuzaki H,Yamamoto T.Protein kinase C delta (PKC delta):activation mechanisms and functions.J Biochem (Tokyo),2002;132:831-9.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部